News Focus
News Focus
icon url

Hoskuld

03/20/25 8:49 PM

#485091 RE: WilliamMunny #485090

Those are my hopes, too Mr. Munny. I don't think anyone should invest thinking the MAA is a sure thing nor thinking that the efficacy of 3-71 trumps the current SoC. But...am hoping that the data combined with no decent, safe alternatives will make the EMA choose to approve (as we would, even objectively.) And I want to think 3-71 is better but...the company itself ran a very small P2, even if they are expanding it a bit, so have to assume their confidence is roughly 50-50, too.
icon url

kund

03/20/25 8:58 PM

#485094 RE: WilliamMunny #485090

Did you notice that Misleading conveniently avoided mentioning the PANSS score when he released the Phase 2 part A data? Guys still hides data. First he runs tiny trial and then takes forever to cherry pick data.

https://www.anavex.com/post/anavex-life-sciences-announces-encouraging-preliminary-biomarker-results-from-ongoing-phase-2-study